Clinical Laserthermia Systems (CLS) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Karl Borrebaeck, was filed 25 Dec 2017.
Clinical Laserthermia Systems (CLS): what insiders have been doing
Every trade that managers of Clinical Laserthermia Systems (CLS) disclose to Finansinspektionen is tracked on this page. Clinical Laserthermia Systems (CLS) has had no insider filing for more than a year; the last one goes back to 25 December 2017.
The full history, which starts in 2017, counts 2 purchases against no sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Financial data
· cache
- 25,000 shares@ SEK 9.9849.9% of flowFI:csv-baa4520dc69b853c45abCanonical exit: 20 Jul 2017 (T+90)
- 25,000 shares@ SEK 9.9850.1% of flowFI:csv-ca7cb48c73ee2f62804aCanonical exit: 24 Jul 2017 (T+90)
2 of 2 declarations
About Clinical Laserthermia Systems (CLS)
Clinical Laserthermia Systems (CLS) is a company focused on developing laser treatment technologies for cancer. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations